Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
S. K. Kumar, J. H. Lee, J. J. Lahuerta, G. Morgan, P. G. Richardson, J. Crowley, J. Haessler, J. Feather, A. Hoering, P. Moreau, X. Leleu, C. Hulin, S. K. Klein, P. Sonneveld, D. Siegel, J. Bladé, H. Goldschmidt, S. Jagannath, J. S. Miguel, R. OrlowskiA. Palumbo, O. Sezer, S. V. Rajkumar, B. G.M. Durie
Research output: Contribution to journal › Article › peer-review
662Scopus
citations
Fingerprint
Dive into the research topics of 'Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study'. Together they form a unique fingerprint.